486 related articles for article (PubMed ID: 24118484)
1. Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO.
Verkman AS; Phuan PW; Asavapanumas N; Tradtrantip L
Brain Pathol; 2013 Nov; 23(6):684-95. PubMed ID: 24118484
[TBL] [Abstract][Full Text] [Related]
2. Optic neuritis in neuromyelitis optica.
Levin MH; Bennett JL; Verkman AS
Prog Retin Eye Res; 2013 Sep; 36():159-71. PubMed ID: 23545439
[TBL] [Abstract][Full Text] [Related]
3. Aquaporin-4: orthogonal array assembly, CNS functions, and role in neuromyelitis optica.
Verkman AS; Ratelade J; Rossi A; Zhang H; Tradtrantip L
Acta Pharmacol Sin; 2011 Jun; 32(6):702-10. PubMed ID: 21552296
[TBL] [Abstract][Full Text] [Related]
4. Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica.
Tradtrantip L; Yao X; Su T; Smith AJ; Verkman AS
Acta Neuropathol; 2017 Jul; 134(1):35-44. PubMed ID: 28567523
[TBL] [Abstract][Full Text] [Related]
5. Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.
Tradtrantip L; Zhang H; Saadoun S; Phuan PW; Lam C; Papadopoulos MC; Bennett JL; Verkman AS
Ann Neurol; 2012 Mar; 71(3):314-22. PubMed ID: 22271321
[TBL] [Abstract][Full Text] [Related]
6. Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies.
Ratelade J; Verkman AS
Int J Biochem Cell Biol; 2012 Sep; 44(9):1519-30. PubMed ID: 22713791
[TBL] [Abstract][Full Text] [Related]
7. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.
Nicchia GP; Mastrototaro M; Rossi A; Pisani F; Tortorella C; Ruggieri M; Lia A; Trojano M; Frigeri A; Svelto M
Glia; 2009 Oct; 57(13):1363-73. PubMed ID: 19229993
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic cleavage of anti-aquaporin-4 autoantibody in neuromyelitis optica by an IgG-selective proteinase.
Tradtrantip L; Asavapanumas N; Verkman AS
Mol Pharmacol; 2013 Jun; 83(6):1268-75. PubMed ID: 23571414
[TBL] [Abstract][Full Text] [Related]
9. Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays.
Phuan PW; Ratelade J; Rossi A; Tradtrantip L; Verkman AS
J Biol Chem; 2012 Apr; 287(17):13829-39. PubMed ID: 22393049
[TBL] [Abstract][Full Text] [Related]
10. Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica.
Ratelade J; Smith AJ; Verkman AS
Exp Neurol; 2014 May; 255():145-53. PubMed ID: 24636863
[TBL] [Abstract][Full Text] [Related]
11. Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays.
Iorio R; Fryer JP; Hinson SR; Fallier-Becker P; Wolburg H; Pittock SJ; Lennon VA
J Autoimmun; 2013 Feb; 40():21-7. PubMed ID: 22906356
[TBL] [Abstract][Full Text] [Related]
12. Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.
Rossi A; Ratelade J; Papadopoulos MC; Bennett JL; Verkman AS
Glia; 2012 Dec; 60(12):2027-39. PubMed ID: 22987455
[TBL] [Abstract][Full Text] [Related]
13. Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica.
Ratelade J; Asavapanumas N; Ritchie AM; Wemlinger S; Bennett JL; Verkman AS
Acta Neuropathol; 2013 Nov; 126(5):699-709. PubMed ID: 23995423
[TBL] [Abstract][Full Text] [Related]
14. Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema.
Ratelade J; Bennett JL; Verkman AS
PLoS One; 2011; 6(11):e27412. PubMed ID: 22076159
[TBL] [Abstract][Full Text] [Related]
15. Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity.
Duan T; Smith AJ; Verkman AS
Acta Neuropathol Commun; 2019 Jul; 7(1):112. PubMed ID: 31296268
[TBL] [Abstract][Full Text] [Related]
16. Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays.
Crane JM; Lam C; Rossi A; Gupta T; Bennett JL; Verkman AS
J Biol Chem; 2011 May; 286(18):16516-24. PubMed ID: 21454592
[TBL] [Abstract][Full Text] [Related]
17. Isotetrandrine Reduces Astrocyte Cytotoxicity in Neuromyelitis Optica by Blocking the Binding of NMO-IgG to Aquaporin 4.
Sun M; Wang J; Zhou Y; Wang Z; Jiang Y; Li M
Neuroimmunomodulation; 2016; 23(2):98-108. PubMed ID: 27064690
[TBL] [Abstract][Full Text] [Related]
18. Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica.
Tradtrantip L; Felix CM; Spirig R; Morelli AB; Verkman AS
Neuropharmacology; 2018 May; 133():345-353. PubMed ID: 29428821
[TBL] [Abstract][Full Text] [Related]
19. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane.
Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C
J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518
[TBL] [Abstract][Full Text] [Related]
20. Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G.
Yao X; Verkman AS
Acta Neuropathol Commun; 2017 Feb; 5(1):15. PubMed ID: 28212662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
